skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Refinado por: tipo de recurso: Videos remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Interview des porteurs de projet lors des CollExPro19 - 7 Pier Luigi Rossi
Interview des porteurs de projet lors des CollExPro19 - 7 Pier Luigi Rossi
Material Type:
Vídeo 		Adicionar ao Meu Espaço

Interview des porteurs de projet lors des CollExPro19 - 7 Pier Luigi Rossi

:none

CollEx-Persée 2019

Texto completo disponível

Citações Citado por
2
Dupilumab Provides Clinically Meaningful Responses in Children Aged 6–11 Years With Severe Atopic Dermatitis: Post-hoc Analysis Results From a Phase III Trial
Dupilumab Provides Clinically Meaningful Responses in Children Aged 6–11 Years With Severe Atopic Dermatitis: Post-hoc Analysis Results From a Phase III Trial
Material Type:
Vídeo 		Adicionar ao Meu Espaço

Dupilumab Provides Clinically Meaningful Responses in Children Aged 6–11 Years With Severe Atopic Dermatitis: Post-hoc Analysis Results From a Phase III Trial

Adis Journals on behalf of ; Siegfried, Elaine C ; Cork, Michael J. ; Katoh, Norito ; Zhang, Haixin ; Chuang, Chien-Chia ; Thomas, Ryan B. ; Rossi, Ana B. ; Cyr, Sonya L. ; Zhang, Annie

Adis Journals 2023

Texto completo disponível

Citações Citado por
3
Caregivers’ and Physicians’ Perspectives on Alpha-Mannosidosis: A Report from Italy
Caregivers’ and Physicians’ Perspectives on Alpha-Mannosidosis: A Report from Italy
Material Type:
Vídeo 		Adicionar ao Meu Espaço

Caregivers’ and Physicians’ Perspectives on Alpha-Mannosidosis: A Report from Italy

Verrecchia, Elena ; Sicignano, Ludovico L. ; Massaro, Maria Grazia ; Rocco, Rossana ; Silvestri, Gabriella ; Rossi, Silvia ; Manna, Raffaele

Adis Journals 2020

Texto completo disponível

Citações Citado por
4
Consistency of Response to Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis Over 1 Year
Consistency of Response to Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis Over 1 Year
Material Type:
Vídeo 		Adicionar ao Meu Espaço

Consistency of Response to Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis Over 1 Year

Adis Journals on behalf of ; Blauvelt, Andrew ; Bruin-Weller, Marjolein de ; Simpson, Eric L. ; Chen, Zhen ; Ardeleanu, Marius ; Rossi, Ana B.

Adis Journals 2021

Texto completo disponível

Citações Citado por
5
Additional file 4 of Public attitudes towards screening for kidney cancer: an online survey
Additional file 4 of Public attitudes towards screening for kidney cancer: an online survey
Material Type:
Vídeo 		Adicionar ao Meu Espaço

Additional file 4 of Public attitudes towards screening for kidney cancer: an online survey

Laragh L. W. Harvey-Kelly ; Harrison, Hannah ; Rossi, Sabrina H. ; Griffin, Simon J. ; Stewart, Grant D. ; Usher-Smith, Juliet A.

figshare 2020

Texto completo disponível

Citações Citado por
6
Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-To-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term Treatment
Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-To-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term Treatment
Material Type:
Vídeo 		Adicionar ao Meu Espaço

Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-To-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term Treatment

of, Adis journals on behalf ; Armstrong, April ; Blauvelt, Andrew ; Simpson, Eric L. ; Smith, Catherine H. ; Herranz, Pedro ; Kataoka, Yoko ; Seong-Jun, Seo ; Ferrucci, Silvia M. ; Chao, Jingdong ; Chen, Zhen ; Rossi, Ana B. ; Shumel, Brad ; Tomondy, Paul

Adis Journals 2021

Texto completo disponível

Citações Citado por
7
Dupilumab Maintains Long-Term Disease Control in Adults With Moderate to Severe Atopic Dermatitis as Measured by Well-Controlled Weeks: Results From the LIBERTY AD CHRONOS Clinical Trial
Dupilumab Maintains Long-Term Disease Control in Adults With Moderate to Severe Atopic Dermatitis as Measured by Well-Controlled Weeks: Results From the LIBERTY AD CHRONOS Clinical Trial
Material Type:
Vídeo 		Adicionar ao Meu Espaço

Dupilumab Maintains Long-Term Disease Control in Adults With Moderate to Severe Atopic Dermatitis as Measured by Well-Controlled Weeks: Results From the LIBERTY AD CHRONOS Clinical Trial

Of, Adis Journals On Behalf ; Jashin J. Wu ; Spelman, Lynda ; Tan, Jerry L. ; Etoh, Takafumi ; Haixin Zhang ; Shumel, Brad ; Rossi, Ana B.

Adis Journals 2021

Texto completo disponível

Citações Citado por
8
Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and Older
Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and Older
Material Type:
Vídeo 		Adicionar ao Meu Espaço

Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and Older

Adis Journals on behalf of ; Simpson, Eric L. ; Paller, Amy S. ; Siegfried, Elaine C. ; Thaçi, Diamant ; Wollenberg, Andreas ; Cork, Michael J. ; Marcoux, Danielle ; Huang, Rui ; Chen, Zhen ; Rossi, Ana B. ; Shumel, Brad ; Sierka, Debra ; Bansal, Ashish

Adis Journals 2021

Texto completo disponível

Citações Citado por
9
Dupilumab in Adults with Moderate-To-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal-Immunosuppressants: Analysis of Four Phase 3 Trials
Dupilumab in Adults with Moderate-To-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal-Immunosuppressants: Analysis of Four Phase 3 Trials
Material Type:
Vídeo 		Adicionar ao Meu Espaço

Dupilumab in Adults with Moderate-To-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal-Immunosuppressants: Analysis of Four Phase 3 Trials

of, Adis journals on behalf ; Griffiths, Christopher ; Bruin-Weller, Marjolein de ; Deleuran, Mette ; Fargnoli, Maria Concetta ; Staumont-Sallé, Delphine ; Hong, Chih-ho ; Sánchez-Carazo, Jose ; Foley, Peter ; Seo, Seong Jun ; Msihid, Jérôme ; Chen, Zhen ; Cyr, Sonya L. ; Rossi, Ana B.

Adis Journals 2021

Texto completo disponível

Citações Citado por
10
Clinically meaningful responses with dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: post hoc analyses from a randomized clinical trial
Clinically meaningful responses with dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: post hoc analyses from a randomized clinical trial
Material Type:
Vídeo 		Adicionar ao Meu Espaço

Clinically meaningful responses with dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: post hoc analyses from a randomized clinical trial

Paller, Amy S. ; Bansal, Ashish ; L. Simpson, Eric ; Boguniewicz, Mark ; Blauvelt, Andrew ; Siegfried, Elaine C. ; Guttman-Yassky, Emma ; Hultsch, Thomas ; Chen, Zhen ; Mina-Osorio, Paola ; Lu, Yufang ; Rossi, Ana B. ; He, Xinyi ; Kamal, Mohamed ; Graham, Neil M. H. ; Pirozzi, Gianluca ; Ruddy, Marcella ; Eckert, Laurent ; Gadkari, Abhijit

Adis Journals 2019

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.